SCORE

19

ATRA: Atara Biotherapeutics, Inc. is a Sell

AAPL chart by TradingView

The current rating for ATRA is 19, which is 163% below its historic median rating of 50. This indicates higher risk than normal.

The rating is currently showing a lower than normal reading, suggesting risk levels could be higher than normal and additional caution is advised.